These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33890344)

  • 21. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.
    Salari M; Etemadifar M; Zali A; Medghalchi A; Tehrani Fateh S; Aminzade Z; Bagheri Moghaddam S
    Mov Disord; 2021 Apr; 36(4):794-795. PubMed ID: 33733511
    [No Abstract]   [Full Text] [Related]  

  • 22. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
    Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
    Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and Parkinsonism: A Critical Appraisal.
    Cavallieri F; Fioravanti V; Bove F; Del Prete E; Meoni S; Grisanti S; Zedde M; Pascarella R; Moro E; Valzania F
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.
    Fearon C; Fasano A
    Int Rev Neurobiol; 2022; 165():35-62. PubMed ID: 36208906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covid-19 Infection and Parkinsonism: Is There a Link?
    Bouali-Benazzouz R; Benazzouz A
    Mov Disord; 2021 Aug; 36(8):1737-1743. PubMed ID: 34080714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    Sorrell L; Leta V; Barnett A; Stevens K; King A; Inches J; Kobylecki C; Walker R; Chaudhuri KR; Martin H; Rideout J; Sneyd JR; Campbell S; Carroll C;
    PLoS One; 2023; 18(7):e0285349. PubMed ID: 37523365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Kaushik A; Kujawska M; Ahmed EA; Batiha GE
    J Neurosci Res; 2023 Jun; 101(6):952-975. PubMed ID: 36717481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spotlight on non-motor symptoms and Covid-19.
    Rota S; Boura I; Wan YM; Lazcano-Ocampo C; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():103-133. PubMed ID: 36208897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
    Conte C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 31. May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
    Spina Tensini F; Spina Tensini T; Franklin GL; Teive HAG
    Parkinsonism Relat Disord; 2020 Aug; 77():20. PubMed ID: 32575004
    [No Abstract]   [Full Text] [Related]  

  • 32. Early clues regarding the pathogenesis of long-COVID.
    Peluso MJ; Deeks SG
    Trends Immunol; 2022 Apr; 43(4):268-270. PubMed ID: 35272932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Vaccines and Motor Symptoms in Parkinson's Disease.
    Cosentino C; Torres L; Vélez M; Nuñez Y; Sánchez D; Armas C; Alvarado M
    Mov Disord; 2022 Jan; 37(1):233. PubMed ID: 34775612
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 and Parkinson's Disease: Possible Links in Pathology and Therapeutics.
    Tiwari S; Yadav N; Singh S
    Neurotox Res; 2022 Oct; 40(5):1586-1596. PubMed ID: 35829997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
    Satheesh NJ; Salloum-Asfar S; Abdulla SA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?
    Bloem BR; Trenkwalder C; Sanchez-Ferro A; Kalia LV; Alcalay R; Chiang HL; Kang UJ; Goetz C; Brundin P; Papa SM
    J Parkinsons Dis; 2021; 11(1):3-8. PubMed ID: 33523021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reply to the letter "SARS-CoV-2 cannot unmask Parkinson's disease if there was none before infection".
    Calculli A; Bocci T; Priori A; Pisani A
    Eur J Neurol; 2023 Sep; 30(9):2948. PubMed ID: 37335886
    [No Abstract]   [Full Text] [Related]  

  • 38. SARS-CoV-2 and COVID-19: A Narrative Review.
    Blann AD; Heitmar R
    Br J Biomed Sci; 2022; 79():10426. PubMed ID: 36148046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
    Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
    J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.